Analgesic effect of electroacupuncture on bone cancer pain in rat model: the role of peripheral P2X3 receptor.
Bone cancer-induced pain
DRG
Electroacupuncture
P2X3 receptor
Journal
Purinergic signalling
ISSN: 1573-9546
Titre abrégé: Purinergic Signal
Pays: Netherlands
ID NLM: 101250499
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
26
10
2021
accepted:
28
03
2022
pubmed:
29
4
2022
medline:
8
3
2023
entrez:
28
4
2022
Statut:
ppublish
Résumé
Upregulation of P2X3 receptor (P2X3R) has been strongly implicated in nociceptive signaling including bone cancer pain (BCP). The present study, using rat bone cancer model, aimed to explore the role of P2X3R in regulating rat pain behavior under the intervention of electroacupuncture (EA). The BCP model was successfully established by injection with MRMT-1 breast cancer cell into the medullary cavity of left tibia for 3 × 10
Identifiants
pubmed: 35478452
doi: 10.1007/s11302-022-09861-7
pii: 10.1007/s11302-022-09861-7
pmc: PMC9984641
doi:
Substances chimiques
Receptors, Purinergic P2X3
0
Analgesics
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13-27Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Références
J Neurosci Methods. 1996 Apr;65(2):167-72
pubmed: 8740594
Pflugers Arch. 2006 Aug;452(5):598-607
pubmed: 16547751
Brain Res. 2006 May 9;1088(1):101-8
pubmed: 16650387
Trends Neurosci. 2003 Jan;26(1):17-22
pubmed: 12495858
Am J Chin Med. 2008;36(4):635-45
pubmed: 18711761
Brain. 2010 Sep;133(9):2549-64
pubmed: 20802203
Front Cell Neurosci. 2018 May 08;12:129
pubmed: 29867362
Brain Res. 2010 May 12;1330:31-44
pubmed: 20302849
J Exp Clin Cancer Res. 2009 Jul 16;28:102
pubmed: 19607689
Exp Neurol. 2020 Dec;334:113482
pubmed: 32979370
Purinergic Signal. 2015 Sep;11(3):321-9
pubmed: 25809868
Mol Med Rep. 2017 Aug;16(2):2009-2015
pubmed: 28656207
Purinergic Signal. 2016 Mar;12(1):139-48
pubmed: 26686228
Purinergic Signal. 2020 Dec;16(4):491-502
pubmed: 33011961
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Pharmacol. 2021 Apr 29;12:593043
pubmed: 33995007
Pain. 2016 Jun;157(6):1239-1247
pubmed: 27186713
Lancet. 1996 Jun 8;347(9015):1604-5
pubmed: 8667873
Mol Pain. 2016 Apr 18;12:
pubmed: 27094551
J Mol Cell Biol. 2014 Apr;6(2):140-53
pubmed: 24755854
JAMA Oncol. 2020 Feb 1;6(2):271-278
pubmed: 31855257
Anesth Analg. 2007 Nov;105(5):1482-8, table of contents
pubmed: 17959986
Purinergic Signal. 2018 Dec;14(4):359-369
pubmed: 30084084
ACS Chem Neurosci. 2021 Sep 15;12(18):3323-3334
pubmed: 34460214
Cancer Sci. 2015 Apr;106(4):430-7
pubmed: 25611164
Gastroenterology. 2019 Jan;156(1):218-226
pubmed: 30340754
Curr Pharm Des. 2007;13(23):2368-84
pubmed: 17692007
Brain Res. 2006 Aug 2;1102(1):78-85
pubmed: 16784725
Eur J Pain. 2012 Nov;16(10):1378-88
pubmed: 22528605
Pain. 2002 Mar;96(1-2):129-40
pubmed: 11932069
Neurosci Lett. 2004 May 6;361(1-3):258-61
pubmed: 15135942
Eur J Pharmacol. 2012 Aug 5;688(1-3):27-34
pubmed: 22634164
Eur J Pain. 2008 Oct;12(7):870-8
pubmed: 18221900
Brain Res. 2005 May 24;1044(2):197-205
pubmed: 15885218
Chin J Integr Med. 2013 May;19(5):374-9
pubmed: 23494326
Exp Neurol. 2006 Apr;198(2):294-302
pubmed: 16490194
Front Oncol. 2021 Mar 22;11:644303
pubmed: 33828987
Front Cell Neurosci. 2013 Nov 22;7:233
pubmed: 24319412
Pain. 2015 Oct;156(10):1892-1905
pubmed: 26049406
J Adv Res. 2020 Aug 13;28:139-148
pubmed: 33364051
Mol Pain. 2019 Jan-Dec;15:1744806919847810
pubmed: 30983496
J Neurosci Res. 2014 Dec;92(12):1703-13
pubmed: 25041872
Cancers (Basel). 2017 Jul 08;9(7):
pubmed: 28698458
Evid Based Complement Alternat Med. 2011;2011:671043
pubmed: 21799687
Neurosci Bull. 2016 Oct;32(5):445-54
pubmed: 27631681
Int J Mol Sci. 2019 Jul 02;20(13):
pubmed: 31269659
Brain Res Bull. 2019 Sep;151:144-152
pubmed: 30458249
Zhongguo Zhen Jiu. 2015 Feb;35(2):161-8
pubmed: 25854026
Glia. 2013 Oct;61(10):1571-81
pubmed: 23918214
Expert Opin Ther Targets. 2014 Apr;18(4):459-72
pubmed: 24512266
Theranostics. 2020 Oct 27;10(26):12189-12203
pubmed: 33204337
Integr Cancer Ther. 2018 Jun;17(2):401-410
pubmed: 28870114